Susan G. Komen @SusanGKomen · 02 Jun 2026
🧬 Francois Bidard, MD, Ph.D. presents SERENA-6 at #ASCO26: Switching to camizestrant + CDK4/6i when ESR1 mutations emerge during first-line therapy improved outcomes through 2 lines of treatment in HR+/HER2- advanced breast cancer @ASCO https://t.co/Iod25y4cyH
576Views
3Likes
1Reposts
0Replies
0Quotes
1Bookmarks
Is that a lot?
0.03×vs 100K–1M median21 891 views is typical
0.55%Reachviews ÷ followers
0.69%Engagement rateof viewers reacted